The recent article by Dorsey et al1 highlights some of the difficulties in the prevention, diagnosis, and treatment of malaria in the United States. However, it fails to mention the critical importance of having intravenous (IV) quinidine available for the management of life-threatening chloroquine-resistant Plasmodium falciparum infection. The following case presentation underscores this problem.
Albrecht H, Lennox J, del Rio C. Quinidine and Malaria. Arch Intern Med. 2001;161(8):1118–1119. doi: